From: Quality of life and hormone use: new validation results of MRS scale
Severity of complaints at baseline | |||||
---|---|---|---|---|---|
No/little (0–4) | Mild (5–8) | Moderate (9–15) | Severe (16+) | ||
Total score | New study | 8.0 (12.9) | 22.9 (12.9) | 32.7 (13.9) | 43.3 (15.5) |
Old study* | 10.8 (10.6) | 32.2 (9.8) | 43.9 (11.8) | 55.1 (13.8) | |
Psychological score | New study | 5.8 (16.5) | 18.2 (19.7) | 28.1 (20.5) | 42.8 (19.8) |
Old study* | 6.0 (14.7) | 27.6 (21.5) | 43.7 (20.6) | 57.1 (17.9) | |
Somatic score | New study | 10.4 (20.4) | 26.1 (20.8) | 36.8 (17.8) | 44.9 (17.3) |
Old study* | 13.8 (17.3) | 34.4 (18.5) | 44.1 (16.9) | 54.8 (15.9) | |
Urogenital score | New study | 2.0 (18.1) | 13.4 (19.0) | 22.5 (22.3) | 36.5 (22.0) |
Old study* | 5.7 (13.9) | 17.0 (20.6) | 27.5 (23.6) | 44.4 (22.6) |